This pathological state, where the biological effects of insulin are diminished, underpins a variety of diseases, including diabetes, metabolic syndrome, and atherosclerotic cardiovascular diseases, manifesting as reduced insulin sensitivity in adipocytes, muscle cells, and hepatocytes, alongside the dysregulation of glucose, lipid, and protein metabolism [1, 3, 4]. This evidence concerns the gene INS and metabolic syndrome.